← All diseases Cancer

Non-Hodgkin lymphoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (62)Meta-analysis (19)Treatment guideline (5)Systematic review (21)Randomized trial (9)Phase 3 study (8)Clinical trial (628)Review article (211)Early study (phase 1 or 2) (53)Description of several patients (388)Laboratory or animal study (21)Commentary or editorial (27) Studies currently seeking participants only (48)

Filter

Publications (1571)

• A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera(®)) in patients with CD20-positive B-cell non-Hodgkin lymphoma. (2022/12/30) ♡
• Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas. (2022/12/30) ♡
• Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia. (2022/12/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Leukemia Cutis As the Initial Manifestation of Chronic Lymphocytic Leukemia Progression. (2022/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Cutaneous Anaplastic Large Cell Lymphoma With Gastric Metastasis. (2022/12/25) ♡
• Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001-2020. (2022/12/25) ♡
• Radiation Therapy in Diffuse Large B-Cell Lymphoma: A Little Boost Gets You Over the Finish Line. (2022/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman. (2022/12/15) ♡
• [Interpretation of Chinese guidelines for diagnosis and treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (2022)]. (2022/12/14) ♡
• [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies]. (2022/12/14) ♡
• [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma]. (2022/12/14) ♡
• [Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma]. (2022/12/14) ♡
• Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment. (2022/12/13) ♡
• Diversity of malignancies in patients with different types of inborn errors of immunity. (2022/12/12) ♡
• Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression. (2022/12/12) ♡
• Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphoma. (2022/12/07) ♡
• Causal relationship between 14 site-specific cancers and venous thromboembolism. (2022/12/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diffuse large B-cell lymphoma: An uncommon diagnosis at the cerebellopontine angle - A case report. (2022/12/06) ♡
• Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis. (2022/12/01) ♡
• A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma. (2022/12/01) ♡
• The dual role of CD70 in B-cell lymphomagenesis. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma]. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Malignant Rectal B Cell Lymphoma That Was Difficult to Differentiate from Rectal Neuroendocrine Tumor]. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Peritoneal Lymphomatosis Diagnosed by Single-Port Laparoscopic Biopsy]. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A Case of Diffuse Large B Cell Lymphoma of the Extrahepatic Bile Duct Cholangiocarcinoma]. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Patient with Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma with Small Intestinal Perforation Development during Chemotherapy]. (2022/12/01) ♡
• [Interpretation of the guidelines for diagnosis and treatment of mantle cell lymphoma in China (2022)]. (2022/11/14) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. [Bendamustine monotherapy for Chinese patient treatment with relapsed or refractory B cell non-Hodgkin lymphoma: a phase Ⅱ, prospective, multicenter, single-arm study]. (2022/11/14) ♡
• Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better. (2022/11/13) ♡
• Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. (2022/11/06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma. (2022/11/01) ♡
• A β-glucan from Aureobasidium pullulans enhanced the antitumor effect with rituximab against SU-DHL-8. (2022/11/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review. (2022/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Unusual Case of High-Grade Non-Hodgkin Lymphoma Masquerading as Acute Pyelonephritis with Acute Kidney Injury. (2022/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type. (2022/11/01) ♡
• CRP Levels as a Prognostic Factor in Mycosis Fungoides. (2022/11/01) ♡
• Commentary on Methodologic choices in synthesizing epidemiologic evidence to assess perchloroethylene and non-Hodgkin's lymphoma. (2022/10/18) ♡
• Commentary: On the reliability of causal claims. (2022/10/17) ♡
• Commentary: Quantifying the impact of bias to inform quality assessments in systematic reviews: The case of perchloroethylene and Non-Hodgkin's lymphoma. (2022/10/17) ♡
• Response: Alternative approaches for systematic review. (2022/10/17) ♡
• [Clonality relatedness and molecular characteristics of Richter transformation]. (2022/10/14) ♡
• Diffuse Large B-Cell Lymphoma of Thyroid: A Case Report and Review of Literature. (2022/10/01) ♡
• Indolent CD30-Positive Extranodal NK/T Cell Lymphoma with Large Cell Transformation: Case Report and Literature Review. (2022/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary pancreatic lymphoma clinically mimicking carcinoma. An important differential diagnostic problem due to the different therapeutic implications. (2022/10/01) ♡
• Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activity. (2022/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group. (2022/10/01) ♡
• Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography - Computed Tomography in Primary Thyroid Lymphoma. (2022/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Atypical MYC rearrangement pattern of 3' deletion and 5' amplification along with independent IGH rearrangement: A case study. (2022/10/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.